摘要
目的探讨乳腺癌中S100A7和AKT在乳腺癌中的表达及其相关性。方法采用免疫组化PV非生物素两步法检测226例乳腺癌中S100A7与AKT的表达及与ER、PR、Her-2表达的关系。结果 S100A7蛋白在乳腺导管原位癌中阳性率增高(52.50%),AKT在乳腺浸润性导管癌中阳性率高(50.00%);S100A7和AKT在伴淋巴结转移的病例中阳性率高(P=0.0062,P=0.044 8);且Ⅲ期乳腺癌阳性率高于Ⅰ和Ⅱ期(P=0.025 8,P=0.040 3)。AKT表达和肿瘤大小相关,差异有显著性(P=0.031 0);S100A7和AKT蛋白在乳腺癌中的表达与ER、PR呈负相关,与Her-2呈正相关,两者之间呈正相关。结论探讨S100A7与AKT蛋白在乳腺癌中的表达具有重要意义,两者有可能成为乳腺癌治疗的新的靶点。
Purpose To understand the different expression of S100A7 and AKT in breast cancer and their correlations. Methods Immunohistochemical PV non-biotin two-step method was used to examine expression of SI00A7 and AKT in 226 cases of breast canc- er, and their correlations with chnicopathological features involving ER, PR, and Her-2 status in breast cancer. Results The expres- sion of S100A7 protein in ductal carcinoma in situ, was high (52. 50% ) , while the positive expression rate of AKT in breast invasive ductal carcinoma increased (50. 00% ) , the expression of both S100A7 and AKT was higher in cases with lymph node metastasis (P = 0. 006 2, P = 0. 044 8), and the expression rate in stage Ⅲ was higher than that in stages I and Ⅱ (P = 0. 025 8, P = 0. 040 3 ). The correlation of AKT expression with tumor size was significant (P = 0. 031 0). The expression of S100A7 and AKT in breast cancer had negative correlation with ER and PR status, and positive correlation with Her-2 amplification. Conclusion Detection of S100A7 and AKT proteins in breast cancer cells plays an important role in the pathologic study, which likely provide new targets for breast cancer treatment.
出处
《临床与实验病理学杂志》
CAS
CSCD
北大核心
2012年第9期963-966,共4页
Chinese Journal of Clinical and Experimental Pathology
基金
辽宁省教育厅高等学校科研项目(L2010570)